ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 5, 2019.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on March 7, 2019, American Radiolabeled Chem, 101 Arc Drive, Saint Louis, Missouri 63146 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Gamma Hydroxybutyric Acid | 2010 | I |
| Ibogaine | 7260 | I |
| Lysergic acid diethylamide | 7315 | I |
| Tetrahydrocannabinols | 7370 | I |
| Dimethyltryptamine | 7435 | I |
| 1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I |
| Dihydromorphine | 9145 | I |
| Heroin | 9200 | I |
| Normorphine | 9313 | I |
| Amphetamine | 1100 | II |
| Methamphetamine | 1105 | II |
| Amobarbital | 2125 | II |
| Phencyclidine | 7471 | II |
| Phenylacetone | 8501 | II |
| Cocaine | 9041 | II |
| Codeine | 9050 | II |
| Dihydrocodeine | 9120 | II |
| Oxycodone | 9143 | II |
| Hydromorphone | 9150 | II |
| Ecgonine | 9180 | II |
| Hydrocodone | 9193 | II |
| Meperidine | 9230 | II |
| Metazocine | 9240 | II |
| Methadone | 9250 | II |
| Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
| Morphine | 9300 | II |
| Oripavine | 9330 | II |
| Thebaine | 9333 | II |
| Oxymorphone | 9652 | II |
| Phenazocine | 9715 | II |
| Carfentanil | 9743 | II |
| Fentanyl | 9801 | II |
The company plans to manufacture small quantities of the above-listed controlled substances as radiolabeled compounds for biochemical research.
Dated: May 24, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-11878 Filed 6-5-19; 8:45 am]
BILLING CODE 4410-09-P